Both in Lab Analytical Instruments
Pacific Biosciences of California vs Bruker
Over the past year PACB returned +8.9% and BRKR returned +46.0%; their daily moves had a correlation of 0.37.
PACB +8.9% BRKR +46.0%Growth of $1, one year, split-adjusted
| Metric | PACB | BRKR |
|---|---|---|
| Price | $2.44 | $56.50 |
| Market cap | $758.4M | $8.61B |
| Today | +4.05% | +1.45% |
| 1 month | −15.0% | −11.5% |
| 6 months | +54.4% | +48.6% |
| Year to date | +30.5% | +19.9% |
| 1 year | +4.3% | +45.1% |
| Revenue growth (YoY) | −1.9% | +5.2% |
| Gross margin | 32.4% | 49.6% |
| Net margin | −114.7% | −7.5% |
| P/E (TTM) | — | — |
| Price / sales | 4.8× | 2.5× |
| Net cash | -$407.5M | -$1.64B |
| Dividend yield | — | 0.35% |
| Volatility (60d) | 116.6% | 50.9% |
| Short % of float | 18.2% | 11.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).